Joint Corp

Joint Corp maintains a strong liquidity position, with $17.46 million in cash and equivalents, representing 21.2% of total assets. The company's price-to-book ratio of 5.05 suggests a premium valuation relative to its book value, while the price-to-tangible-book ratio is identical, indicating no intangible asset discounting. The company's liquidity risk is assessed as low, with no immediate filing-based liquidity flags detected.

Profitability metrics show a challenging performance, with a negative return on equity of -15.51% and a return on assets of -4.36%, both significantly below industry norms. Operating income is negative at -$1.78 million, and net income is -$3.60 million, indicating operational inefficiencies or high costs relative to revenue.

Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue is concentrated in a single business line, as no segment breakdown is provided. This lack of diversification may increase exposure to sector-specific risks.

The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. Analysts have assigned a mean price target of $10.00, suggesting a potential upside from the current market price of $8.21. However, the absence of positive earnings and the negative operating cash flow of $1.84 million raise concerns about long-term growth sustainability.

Risk factors include the company's negative net income and operating income, which could impact its ability to service debt or fund operations without external financing. The dilution risk is assessed as low, with no immediate filing-based dilution flags detected. However, the company's free cash flow is negative at -$448,610, which may necessitate future capital raises.

Recent events include the publication of the latest financial data, which shows a revenue of $12.61 million and a gross profit of $9.80 million. No recent filings or transcripts have been disclosed that would indicate significant operational or strategic changes.

Joint Corp (JYNT.O) is undergoing its first formal analysis, establishing a baseline for future performance tracking rather than reflecting a specific recent operational shift. As this is the initial assessment for the ticker, there are no prior data points to compute material changes or deltas in financial metrics, executive movements, or strategic pivots. Consequently, the current snapshot serves as a foundational reference point for investors and analysts beginning to monitor the company’s trajectory. The company’s current profile is defined by a lean leadership structure and limited institutional coverage. Joint Corp operates with only two officers and is followed by just two analysts, suggesting a niche market presence or early-stage visibility. Furthermore, the firm holds no index memberships, which may indicate it is not yet a constituent of major benchmark indices, potentially affecting its liquidity and passive investment inflows. Despite the lack of index inclusion, Joint Corp maintains a shareholder base comprising 20 top holders, indicating a degree of concentrated ownership interest. This holder count provides a starting point for understanding capital structure stability, though the absence of prior data prevents any analysis of changes in holder composition or concentration trends over time. External macro-environmental factors are currently influencing the broader context in which Joint Corp operates, though direct causal links to the company’s specific operations are not detailed in the available facts. The firm is situated within a landscape marked by high-intensity sagas such as "U.S. Military Strikes Iran-Flagged Oil Tankers" and "Global Maritime Strategy Shift," alongside regulatory pressures like "ICE Enforcement Scrutiny." These themes suggest that geopolitical and regulatory risks are prominent in the sectors relevant to Joint Corp’s business environment.

Analysts project 14.2% upside to a mean price target of $10.00, suggesting undervaluation relative to current market price.

The company eliminated long-term debt by FY2025, resulting in a zero debt-to-equity ratio and reduced financial leverage risk.

Net income surged 150.2% year-over-year in FY2026, reaching $2.9 million, indicating a potential return to profitability.

Revenue grew 5.2% year-over-year in FY2026 to $54.9 million, demonstrating top-line expansion despite recent volatility.

Dilution and liquidity risks are assessed as low, providing a stable capital structure environment for shareholders.

Operating and net margins rank in the bottom quartile of the healthcare cohort, signaling severe profitability challenges.

The company faces high credit risk, which may hinder its ability to secure favorable financing terms in the future.

Revenue declined at a 9.0% CAGR over four years, reflecting a long-term contraction in business scale.

Revenue $14.8M, +13,3% YoY.

• ▍Revenue $14.8M, +13,3% YoY

Revenue $15.2M, +3,1% YoY; Operating income −8,3% YoY.

• ▍Revenue $15.2M, +3,1% YoY
• ▍Operating income −8,3% YoY
• ▍Net income +5 508,9% YoY
• ▍Free cash flow −12,7% YoY
• ▍Net margin 6.5%

Revenue $13.4M, +5,7% YoY; Operating income +132,7% YoY.

• ▍Revenue $13.4M, +5,7% YoY
• ▍Operating income +132,7% YoY
• ▍Net income +127,0% YoY
• ▍Free cash flow −25,0% YoY
• ▍Net margin 6.4%

Revenue $13.3M, +5,2% YoY; Operating income +36,0% YoY.

• ▍Revenue $13.3M, +5,2% YoY
• ▍Operating income +36,0% YoY
• ▍Net income +102,6% YoY
• ▍Free cash flow −139,7% YoY
• ▍Net margin 0.7%

Revenue $13.1M; Operating income -$678.5k.

• ▍Revenue $13.1M
• ▍Operating income -$678.5k
• ▍Net margin 6.1%

Revenue $14.7M; Operating income $809.7k.

• ▍Revenue $14.7M
• ▍Operating income $809.7k
• ▍Net margin 0.1%

Revenue $12.7M; Operating income -$492.8k.

• ▍Revenue $12.7M
• ▍Operating income -$492.8k
• ▍Net margin -25.0%

Revenue $12.6M; Operating income -$1.8M.

• ▍Revenue $12.6M
• ▍Operating income -$1.8M
• ▍Net margin -28.5%

Revenue $54.9M, +5,2% YoY; Operating income +51,6% YoY.

• ▍Revenue $54.9M, +5,2% YoY
• ▍Operating income +51,6% YoY
• ▍Net income +150,2% YoY
• ▍Free cash flow −103,0% YoY
• ▍Net margin 5.3%

Revenue $52.2M, +11,0% YoY; Operating income −693,5% YoY.

• ▍Revenue $52.2M, +11,0% YoY
• ▍Operating income −693,5% YoY
• ▍Net income +40,6% YoY
• ▍Free cash flow +113,3% YoY
• ▍Net margin -11.1%

Revenue $47.0M, −53,6% YoY; Operating income −61,6% YoY.

• ▍Revenue $47.0M, −53,6% YoY
• ▍Operating income −61,6% YoY
• ▍Net income −1 656,1% YoY
• ▍Free cash flow −1 154,4% YoY
• ▍Net margin -20.8%

Revenue $101.3M, +26,6% YoY; Operating income −86,5% YoY.

• ▍Revenue $101.3M, +26,6% YoY
• ▍Operating income −86,5% YoY
• ▍Net income −91,7% YoY
• ▍Free cash flow −69,4% YoY
• ▍Net margin 0.6%